Match Document Document Title
US20140025310 METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPY  
The present invention concerns the determination of weighted phenotypic sensitivity score (wPSS) for a combination therapy as being the combination of information about the inherent anti-viral...
US20120095739 METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPY  
The present invention concerns the determination of weighted phenotypic sensitivity score (wPSS) for a combination therapy as being the combination of information about the inherent anti-viral...
US20140080718 Systems and Methods for Identifying Sequence Variation Associated with Genetic Diseases  
Systems and method for identifying variants associated with a genetic disease can include obtaining calls for a plurality of individuals for a list of variant positions. The calls can be compared...
US20110229488 PROGASTRIN AND LIVER PATHOLOGIES  
Progastrin levels are determined to diagnose one or more liver pathologies.
US20140296085 METHOD OF PREDICTING BREAST CANCER PROGNOSIS  
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts,...
US20130013215 COMPUTATIONAL METHODS FOR PROTEIN STRUCTURE DETERMINATION  
A screening method for determining secondary structures of a protein or polypeptide without performing computer simulation, is provided. The screening method is based in part on the interaction...
US20130024125 STATISTICAL ANALYSIS OF MEDICAL THERAPY OUTCOMES  
A method for evaluating a medical therapy with a computing device comprises accessing a data storage system to obtain baseline characteristics for a population of patients who each receive a...
US20150152507 BIOMARKERS FOR PROSTATE CANCER  
The present application concerns methods and tools for diagnosing prostate cancer and furthermore concerns methods and tools for prognosing disease progression of prostate cancer. The method...
US20150142332 HEALTH CARE SYSTEM AND METHOD USING STRESS INDEX ACQUIRED FROM HEART RATE VARIATION  
A health care system and method using human body indexes acquired from human body information are disclosed. The present health care method includes receiving human body information, calculating a...
US20140005947 HEALTH CARE SYSTEM AND METHOD USING STRESS INDEX ACQUIRED FROM HEART RATE VARIATION  
A health care system and method using human body indexes acquired from human body information are disclosed. The present health care method includes receiving human body information, calculating a...
US20060177871 Murine IL-18 crystal structure  
A novel murine IL-18 native crystalline structure is identified.
US20150176072 MOLECULAR MALIGNANCY IN MELANOCYTIC LESIONS  
Disclosed are methods for determining whether a melanocyte-containing sample (such as a nevus or other pigmented lesion) is benign or a primary melanoma. These methods can include detecting (at...
US20110153534 Expression Profiles to Predict Relapse of Prostate Cancer  
The present invention provides a method for preparing a reference model for cancer relapse prediction that provides higher resolution grading than Gleason score alone. The method encompasses...
US20150213208 WEARABLE DEVICE FOR MEDICAL CARE  
The instant disclosure relates to a wearable device for medical care. The device can be worn by the medical staff to help care recipients. The device includes a measuring module, a storing module,...
US20120072118 VARIATION ANALYSIS FOR MULTIPLE TEMPLATES ON A SOLID SUPPORT  
Disclosed herein are compositions and methods used for detecting different types of molecules associated with a site on a solid support.
US20110281364 METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS  
A process for the diagnosis of diabetes mellitus comprising the step of determining the presence or absence or amplitude of at least three polypeptide markers in a urine sample, the polypeptide...
US20140113320 METHODS FOR DETERMINING THE RISK OF PRENATAL COMPLICATIONS  
The disclosure relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual has for developing pre-eclampsia based on amounts of certain...
US20140113319 METHODS FOR DETERMINING THE RISK OF PRENATAL COMPLICATIONS  
The disclosure relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual has for developing pre-eclampsia based on amounts of certain...
US20130344503 METHODS FOR DETERMINING THE RISK OF PRENATAL COMPLICATIONS  
The disclosure relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual has for developing pre-eclampsia based on amounts of certain...
US20140228246 ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF  
The present disclosure relates to an Extra Cellular Matrix composition specific for cancer type and a tumor microenvironment platform for long term culturing of tumor tissue, wherein said...
US20100312484 SYSTEM FOR MONITORING OF AND MANAGING COMPLIANCE WITH TREATMENT FOR OBSTRUCTIVE SLEEP APNEA USING ORAL APPLIANCE THERAPY AND METHOD THERFOR  
A system and method for monitoring of and managing compliance with treatment for obstructive sleep apnea using oral appliance therapy comprises a sensor module installed in an oral appliance, a...
US20120101002 Lung Cancer Biomarkers and Uses Thereof  
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of non-small cell lung cancer and general cancer. In one aspect, methods...
US20150225799 METHODS FOR PREDICTING THE OUTCOME OF A CANCER IN A PATIENT BY ANALYSING GENE EXPRESSION  
The present invention relates to a method for predicting the outcome of a cancer in a patient by analysing gene expression in a sample obtained from said patient. More particularly the present...
US20140278133 SYSTEMS AND METHODS FOR DISEASE ASSOCIATED HUMAN GENOMIC VARIANT ANALYSIS AND REPORTING  
Systems and methods for disease associated human genomic variant analysis and reporting is disclosed. The systems and methods include receiving and extracting disease related variant information;...
US20150197808 CYTOKINES AS PROGNOSTIC MARKERS OF RESPIRATORY-TRACT INFECTION FOLLOWING MAJOR SURGERY  
The invention relates to the use of a certain subset of cytokine markers as prognostic variables of infection status in an individual, and especially as prognostic markers of a patients developing...
US20110196614 BLOOD TRANSCRIPTIONAL SIGNATURE OF MYCOBACTERIUM TUBERCULOSIS INFECTION  
The present invention includes methods, systems and kits for distinguishing between active and latent mycobacterium tuberculosis infection in a patient suspected of being infected with...
US20120109535 Gene Expression Profiles to Predict Relapse of Prostate Cancer  
The present disclosure provides a method for cancer relapse prediction that provides higher resolution grading than Gleason score alone. In particular, the method provides for prediction of...
US20150211077 Methods and Systems for Determining a Likelihood of Adverse Prostate Cancer Pathology  
The present disclosure provides methods that find use in determining a likelihood of adverse prostate cancer pathology in a subject. The methods generally involve detection of one or more...
US20150241406 Means and Methods for Diagnosing Recurrence of Prostate Cancer After Prostatectomy  
The present invention concerns means and methods for cancer diagnosis and, in particular, diagnosis of prostate cancer. Specifically, it relates to a method for diagnosing whether a subject is at...
US20120165217 Cancer Biomarkers and Uses Thereof  
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, the disclosure provides biomarkers that can be...
US20140162887 METHODS OF USING GENE EXPRESSION SIGNATURES TO SELECT A METHOD OF TREATMENT, PREDICT PROGNOSIS, SURVIVAL, AND/OR PREDICT RESPONSE TO TREATMENT  
Methods and compositions for determining and/or predicting a response to a therapy, prognosis of a cancer subject or survival of a cancer and kits for performing the same are described herein.
US20110269638 Genes associated with post relapse survival and uses thereof  
Provided are methods, systems and kits for predicting post-relapse survival of a cancer patient and for identifying cancer genes predictive of the post-relapse survival of the patient. Values...
US20140195168 CONSTRUCTING A DIFFERENTIAL DIAGNOSIS AND DISEASE RANKING IN A LIST OF DIFFERENTIAL DIAGNOSIS  
Disclosed is a system and method for developing a differential diagnosis list or disease ranking in a list of differential diagnosis or identifying a unique disease process when the etiology of...
US20130196321 Gene Expression Profile Algorithm and Test for Determining Prognosis of Prostate Cancer  
The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes, or their co-expressed genes, from a biological sample obtained from a...
US20110238322 METHODS OF SIMULATING CHEMOTHERAPY FOR A PATIENT  
The present invention provides methods for predicting or modeling a chemotherapy outcome for a given patient The method produces chemoresponse data, and presents the chemoresponse data in a...
US20090143994 Managing Body Composition  
Among other things, at least two different independent providers of body composition management services are enabled to have online access through respective graphical user interfaces to body...
US20150038357 PROGNOSIS FOR GLIOMA  
Disclosed is a method of determining the survival prognosis of a patient afflicted by a glioma. The method includes assessing the level of expression of one or more specific gene in cells of the...
US20110020317 BREAST TUMOUR GRADING  
We describe a method of assigning a grade to a breast tumour, which grade is indicative of the aggressiveness of the tumour, the method comprising detecting the expression of a gene selected from...
US20110129920 BIOMARKERS FOR ALZHEIMER'S DISEASE  
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this...
US20120087864 METHOD FOR DIAGNOSING AND/OR EVALUATING RETINAL DISEASE  
The present application provides a method for diagnosing and/or evaluating the presence or absence, severity or degree of the improvement of a retinal disease in a subject, which comprises...
US20110046894 METHOD FOR DISCRIMINATING BETWEEN MALIGNANT AND BENIGN TISSUE LESIONS  
An embodiment of the present invention includes a method for discriminating between benign and malignant tissue lesions. The method includes the steps of using a plurality of maps of physiology...
US20110287968 Methylation Assay  
The present invention discloses a method of generating subsets of methylation specific markers from a set, having diagnostic power for various diseases, e.g. cancer of thyroid, breast, colon, or...
US20150142331 METHODS AND DEVICES FOR ASSESSING RISK OF FEMALE INFERTILITY  
The invention generally relates to methods and devices for assessing risk of female infertility. In certain aspects, methods of the invention involve obtaining a sample, conducting an assay on at...
US20120277999 METHODS, KITS AND ARRAYS FOR SCREENING FOR, PREDICTING AND IDENTIFYING DONORS FOR HEMATOPOIETIC CELL TRANSPLANTATION, AND PREDICTING RISK OF HEMATOPOIETIC CELL TRANSPLANT (HCT) TO INDUCE GRAFT VS. HOST DISEASE (GVHD)  
The invention relates to predicting or determining risk of a hematopoietic cell transplant (HCT) from a donor to induce Graft vs. Host Disease (GVHD) in a HCT recipient; to classifying HCT from a...
US20130046481 Dual-Spectrum Heat Pattern Separation Algorithm For Assessing Chemotherapy Treatment Response And Early Detection  
It is developed a Dual-Spectrum Heat Pattern Separation (DS-HPS) algorithm to quantify the energy from the area of the high temperature tissues, called qH map, and decompose the body surface into...
US20110313674 INSULIN OPTIMIZATION SYSTEMS AND TESTING METHODS WITH ADJUSTED EXIT CRITERION ACCOUNTING FOR SYSTEM NOISE ASSOCIATED WITH BIOMARKERS  
Embodiments of a testing method for optimizing a therapy to a diabetic patient comprise collecting at least one sampling set of biomarker data, computing a probability distribution function, a...
US20140018258 METHODS FOR GENETIC ANALYSIS  
Methods of treating an individual exhibiting a medical condition are disclosed. The methods involve determining a score of an individual based on the individual's genotypic information, comparing...
US20150019138 SYSTEMS AND METHODS FOR DETERMINING INGREDIENT AMOUNTS FOR PREPARATIONS FOR ADMINISTRATION TO PATIENTS  
Computer systems and non-transitory computer readable media for determining an amount of an ingredient for a preparation for a requested therapy (e.g., an order or a prescription) includes an...
US20140278126 High-Resolution Melt Curve Classification Using Neural Networks  
The present invention relates to a method and system for classifying high-resolution melt (“HRM”) curves, and, more specifically, to a method and system for classifying HRM curves by genotype...
US20140365138 SYSTEMS AND METHODS FOR PATTERN RECOGNITION IN DIABETES MANAGEMENT  
A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological...